Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	carbonate dehydratase activity	CA13 CA3 CA5A CA7	4.17e-06	16	142	4	GO:0004089
GeneOntologyMolecularFunction	medium-chain fatty acid omega-hydroxylase activity	CYP4A11 CYP4A22	5.02e-05	2	142	2	GO:0140981
GeneOntologyMolecularFunction	16-hydroxypalmitate dehydrogenase activity	CYP4A11 CYP4A22	5.02e-05	2	142	2	GO:0103002
GeneOntologyMolecularFunction	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen	CYP4A11 CYP27A1 CYP4A22	9.56e-05	13	142	3	GO:0016713
GeneOntologyMolecularFunction	structural constituent of synapse	ACTB ACTG1 RIMS1 RIMS2	2.22e-04	42	142	4	GO:0098918
GeneOntologyMolecularFunction	glycosyltransferase activity	DPY19L3 ABO GALNT1 RPN2 TIPARP XYLT1 TMEM260 GYG2 UGT3A2	2.24e-04	288	142	9	GO:0016757
GeneOntologyMolecularFunction	phosphoric ester hydrolase activity	PDE1B DUSP5 DUSP9 PON1 PTPRU PTPRT GDPD4 FIG4 SSH3 CA3	4.49e-04	386	142	10	GO:0042578
GeneOntologyMolecularFunction	fibroblast growth factor receptor activity	FGFR3 FGFR2	4.95e-04	5	142	2	GO:0005007
GeneOntologyMolecularFunction	hydrolase activity, acting on ester bonds	PDE1B DUSP5 DUSP9 PON1 PTPRU PTPRT GDPD4 PPT1 FIG4 LIPM PXDNL SSH3 PGAP1 ALKBH3 CA3	6.39e-04	807	142	15	GO:0016788
GeneOntologyMolecularFunction	hexosyltransferase activity	DPY19L3 ABO GALNT1 RPN2 TMEM260 GYG2 UGT3A2	7.94e-04	211	142	7	GO:0016758
GeneOntologyMolecularFunction	protein tyrosine phosphatase activity	DUSP5 DUSP9 PTPRU PTPRT SSH3	8.49e-04	103	142	5	GO:0004725
GeneOntologyMolecularFunction	fibroblast growth factor binding	FGFR3 FGFR2 KLB	9.09e-04	27	142	3	GO:0017134
GeneOntologyMolecularFunction	leukotriene-B4 20-monooxygenase activity	CYP4A11 CYP4A22	1.03e-03	7	142	2	GO:0050051
GeneOntologyMolecularFunction	alkane 1-monooxygenase activity	CYP4A11 CYP4A22	1.03e-03	7	142	2	GO:0018685
GeneOntologyMolecularFunction	hydro-lyase activity	CA13 CA3 CA5A CA7	1.05e-03	63	142	4	GO:0016836
GeneOntologyMolecularFunction	iron ion binding	CYP4A11 FA2H CYP27A1 CYP4A22 TET1 ALKBH3	1.22e-03	166	142	6	GO:0005506
GeneOntologyMolecularFunction	phosphatidylinositol 3-kinase inhibitor activity	WDR81 RUBCN	1.37e-03	8	142	2	GO:0141039
GeneOntologyMolecularFunction	structural constituent of presynaptic active zone	RIMS1 RIMS2	1.37e-03	8	142	2	GO:0098882
GeneOntologyMolecularFunction	ribosome binding	RPN2 NOMO1 NOMO2 EIF2A NOMO3	1.68e-03	120	142	5	GO:0043022
GeneOntologyMolecularFunction	transition metal ion binding	ABO GALNT1 CYP4A11 DTX1 FA2H CYP27A1 CA13 CYP4A22 TRIM16 ABCC8 DTX4 TET1 ALKBH3 KDM2B ZMYM4 CA3 CA5A CA7	1.96e-03	1189	142	18	GO:0046914
GeneOntologyMolecularFunction	arachidonate omega-hydroxylase activity	CYP4A11 CYP4A22	2.18e-03	10	142	2	GO:0052869
GeneOntologyMolecularFunction	fatty acid omega-hydroxylase activity	CYP4A11 CYP4A22	2.18e-03	10	142	2	GO:0120250
GeneOntologyMolecularFunction	MAP kinase tyrosine phosphatase activity	DUSP5 DUSP9	2.18e-03	10	142	2	GO:0033550
GeneOntologyMolecularFunction	long-chain fatty acid omega-hydroxylase activity	CYP4A11 CYP4A22	2.18e-03	10	142	2	GO:0102033
GeneOntologyCellularComponent	endoplasmic reticulum membrane	LRRC8C DPY19L3 EMC1 GALNT1 RPN2 CYP4A11 FA2H PON1 WDR81 GRIN2C ATG2A ATP10D CYP4A22 NOMO1 TMEM260 NOMO2 PGAP1 TRPM8 UGT3A2 SCFD1 SYVN1 NOMO3 SEZ6L	2.02e-05	1293	142	23	GO:0005789
GeneOntologyCellularComponent	endoplasmic reticulum subcompartment	LRRC8C DPY19L3 EMC1 GALNT1 RPN2 CYP4A11 FA2H PON1 WDR81 GRIN2C ATG2A ATP10D CYP4A22 NOMO1 TMEM260 NOMO2 PGAP1 TRPM8 UGT3A2 SCFD1 SYVN1 NOMO3 SEZ6L	2.18e-05	1299	142	23	GO:0098827
GeneOntologyCellularComponent	multi-pass translocon complex	NOMO1 NOMO2 NOMO3	2.50e-05	9	142	3	GO:0160064
GeneOntologyCellularComponent	nuclear outer membrane-endoplasmic reticulum membrane network	LRRC8C DPY19L3 EMC1 GALNT1 RPN2 CYP4A11 FA2H PON1 WDR81 GRIN2C ATG2A ATP10D CYP4A22 NOMO1 TMEM260 NOMO2 PGAP1 TRPM8 UGT3A2 SCFD1 SYVN1 NOMO3 SEZ6L	3.04e-05	1327	142	23	GO:0042175
GeneOntologyCellularComponent	presynaptic cytoskeleton	ACTG1 RIMS1 RIMS2	1.06e-04	14	142	3	GO:0099569
GeneOntologyCellularComponent	ER membrane insertion complex	NOMO1 NOMO2 NOMO3	1.06e-04	14	142	3	GO:0072379
GeneOntologyCellularComponent	KICSTOR complex	SZT2 KICS2	2.72e-04	4	142	2	GO:0140007
GeneOntologyCellularComponent	blood microparticle	ACTB PON1 ACTG1 C1R C3 EIF2A	4.57e-04	144	142	6	GO:0072562
GeneOntologyCellularComponent	presynaptic active zone cytoplasmic component	OSBPL2 RIMS1 RIMS2	4.92e-04	23	142	3	GO:0098831
GeneOntologyCellularComponent	dense body	ACTB ACTG1	9.41e-04	7	142	2	GO:0097433
GeneOntologyCellularComponent	cell cortex	SPIRE2 ACTB AXIN1 OSBPL2 TCL1A RIMS1 FGFR2 RIMS2 IQGAP3	9.99e-04	371	142	9	GO:0005938
GeneOntologyCellularComponent	cytoskeleton of presynaptic active zone	RIMS1 RIMS2	1.25e-03	8	142	2	GO:0048788
Domain	Carbonic_anhydrase_a-class_CS	CA13 CA3 CA5A CA7	1.51e-06	12	142	4	IPR018338
Domain	-	GTF2IRD2B GTF2I GTF2IRD2	1.71e-06	4	142	3	3.90.1460.10
Domain	DUF2012	NOMO1 NOMO2 NOMO3	1.71e-06	4	142	3	PF09430
Domain	DUF2012	NOMO1 NOMO2 NOMO3	1.71e-06	4	142	3	IPR019008
Domain	GTF2I	GTF2IRD2B GTF2I GTF2IRD2	1.71e-06	4	142	3	PS51139
Domain	GTF2I	GTF2IRD2B GTF2I GTF2IRD2	1.71e-06	4	142	3	PF02946
Domain	GTF2I	GTF2IRD2B GTF2I GTF2IRD2	1.71e-06	4	142	3	IPR004212
Domain	Carbonic_anhydrase_a-class	CA13 CA3 CA5A CA7	4.10e-06	15	142	4	IPR023561
Domain	ALPHA_CA_1	CA13 CA3 CA5A CA7	4.10e-06	15	142	4	PS00162
Domain	Carb_anhydrase	CA13 CA3 CA5A CA7	7.06e-06	17	142	4	PF00194
Domain	Carb_anhydrase	CA13 CA3 CA5A CA7	7.06e-06	17	142	4	SM01057
Domain	-	CA13 CA3 CA5A CA7	7.06e-06	17	142	4	3.10.200.10
Domain	ALPHA_CA_2	CA13 CA3 CA5A CA7	7.06e-06	17	142	4	PS51144
Domain	Carbonic_anhydrase_a	CA13 CA3 CA5A CA7	7.06e-06	17	142	4	IPR001148
Domain	Carb-bd-like_fold	NOMO1 NOMO2 NOMO3	2.34e-05	8	142	3	IPR013784
Domain	WWE	DTX1 TIPARP DTX4	9.00e-05	12	142	3	PF02825
Domain	WWE-dom	DTX1 TIPARP DTX4	9.00e-05	12	142	3	IPR004170
Domain	WWE	DTX1 TIPARP DTX4	9.00e-05	12	142	3	PS50918
Domain	CarboxyPept_regulatory_dom	NOMO1 NOMO2 NOMO3	1.16e-04	13	142	3	IPR014766
Domain	-	NOMO1 NOMO2 NOMO3	1.16e-04	13	142	3	2.60.40.1120
Domain	CarboxyPept-like_regulatory	NOMO1 NOMO2 NOMO3	2.71e-04	17	142	3	IPR008969
Domain	WWE	DTX1 DTX4	3.41e-04	4	142	2	SM00678
Domain	WWE-dom_subgr	DTX1 DTX4	3.41e-04	4	142	2	IPR018123
Domain	FGF_rcpt_fam	FGFR3 FGFR2	3.41e-04	4	142	2	IPR016248
Domain	TYR_PHOSPHATASE_1	DUSP5 DUSP9 PTPRU PTPRT SSH3	5.03e-04	86	142	5	PS00383
Domain	TYR_PHOSPHATASE_dom	DUSP5 DUSP9 PTPRU PTPRT SSH3	5.30e-04	87	142	5	IPR000387
Domain	TYR_PHOSPHATASE_2	DUSP5 DUSP9 PTPRU PTPRT SSH3	5.30e-04	87	142	5	PS50056
Domain	-	DUSP5 DUSP9 PTPRU PTPRT SSH3	6.85e-04	92	142	5	3.90.190.10
Domain	Quinoprotein_ADH-like_supfam	EMC1 WDR6 WDR87 WDR17	7.02e-04	53	142	4	IPR011047
Domain	Alpha_kinase	TRPM6 EEF2K	8.44e-04	6	142	2	PF02816
Domain	MHCK_EF2_kinase	TRPM6 EEF2K	8.44e-04	6	142	2	IPR004166
Domain	ALPHA_KINASE	TRPM6 EEF2K	8.44e-04	6	142	2	PS51158
Domain	Alpha_kinase	TRPM6 EEF2K	8.44e-04	6	142	2	SM00811
Domain	Prot-tyrosine_phosphatase-like	DUSP5 DUSP9 PTPRU PTPRT SSH3	9.55e-04	99	142	5	IPR029021
Domain	fn3	CHL1 BOC OBSCN PTPRU PTPRT USH2A	1.51e-03	162	142	6	PF00041
Domain	ACTINS_1	ACTB ACTG1	1.56e-03	8	142	2	PS00406
Domain	DUSP	DUSP5 DUSP9 SSH3	1.65e-03	31	142	3	IPR024950
Domain	TYR_PHOSPHATASE_DUAL	DUSP5 DUSP9 SSH3	2.17e-03	34	142	3	PS50054
Domain	Tyr_Pase_AS	DUSP5 PTPRU PTPRT SSH3	2.32e-03	73	142	4	IPR016130
Domain	DSPc	DUSP5 DUSP9 SSH3	2.36e-03	35	142	3	SM00195
Domain	TYR_PHOSPHATASE_DUAL_dom	DUSP5 DUSP9 SSH3	2.36e-03	35	142	3	IPR020422
Domain	MKP	DUSP5 DUSP9	2.48e-03	10	142	2	IPR008343
Domain	Ig-like_fold	CHL1 BOC OBSCN PTPRU PTPRT NOMO1 NOMO2 PXDNL FGFR3 FGFR2 SEMA4A USH2A NOMO3	2.87e-03	706	142	13	IPR013783
Domain	FN3	CHL1 BOC OBSCN PTPRU PTPRT USH2A	2.93e-03	185	142	6	SM00060
Domain	ZF_CXXC	TET1 KDM2B	3.02e-03	11	142	2	PS51058
Domain	FYVE_2	RIMS1 RIMS2	3.02e-03	11	142	2	PF02318
Domain	Znf_CXXC	TET1 KDM2B	3.02e-03	11	142	2	IPR002857
Domain	zf-CXXC	TET1 KDM2B	3.02e-03	11	142	2	PF02008
Domain	Ig_I-set	CHL1 BOC OBSCN PXDNL FGFR3 FGFR2	3.34e-03	190	142	6	IPR013098
Domain	I-set	CHL1 BOC OBSCN PXDNL FGFR3 FGFR2	3.34e-03	190	142	6	PF07679
Domain	RABBD	RIMS1 RIMS2	3.60e-03	12	142	2	PS50916
Domain	Rab_BD	RIMS1 RIMS2	3.60e-03	12	142	2	IPR010911
Domain	Dual-sp_phosphatase_cat-dom	DUSP5 DUSP9 SSH3	3.71e-03	41	142	3	IPR000340
Domain	DSPc	DUSP5 DUSP9 SSH3	3.71e-03	41	142	3	PF00782
Domain	-	WDR81 WDR26 TBC1D31 WDR6 WDR87 SEMA4A EIF2A WDR17	4.00e-03	333	142	8	2.130.10.10
Domain	WD40/YVTN_repeat-like_dom	WDR81 WDR26 TBC1D31 WDR6 WDR87 SEMA4A EIF2A WDR17	4.14e-03	335	142	8	IPR015943
Domain	FN3	CHL1 BOC OBSCN PTPRU PTPRT USH2A	4.19e-03	199	142	6	PS50853
Domain	-	CHL1 BOC OBSCN PTPRU PTPRT NOMO1 NOMO2 PXDNL FGFR3 FGFR2 USH2A NOMO3	4.74e-03	663	142	12	2.60.40.10
Domain	Cyt_P450_E_grp-I	CYP4A11 CYP27A1 CYP4A22	4.83e-03	45	142	3	IPR002401
Domain	FN3_dom	CHL1 BOC OBSCN PTPRU PTPRT USH2A	5.31e-03	209	142	6	IPR003961
Domain	WD_REPEATS_1	WDR81 WDR26 TBC1D31 WDR6 WDR87 EIF2A WDR17	5.43e-03	278	142	7	PS00678
Domain	WD_REPEATS_2	WDR81 WDR26 TBC1D31 WDR6 WDR87 EIF2A WDR17	5.53e-03	279	142	7	PS50082
Domain	WD_REPEATS_REGION	WDR81 WDR26 TBC1D31 WDR6 WDR87 EIF2A WDR17	5.53e-03	279	142	7	PS50294
Domain	CUB	PAMR1 C1R SEZ6L	6.14e-03	49	142	3	PF00431
Domain	MAM_1	PTPRU PTPRT	6.42e-03	16	142	2	PS00740
Domain	Actin_CS	ACTB ACTG1	6.42e-03	16	142	2	IPR004001
Domain	CUB	PAMR1 C1R SEZ6L	6.50e-03	50	142	3	SM00042
Domain	MAM	PTPRU PTPRT	7.24e-03	17	142	2	SM00137
Domain	ACTINS_2	ACTB ACTG1	7.24e-03	17	142	2	PS00432
Domain	-	PAMR1 C1R SEZ6L	7.24e-03	52	142	3	2.60.120.290
Domain	Sushi	PAMR1 C1R SEZ6L	7.24e-03	52	142	3	PF00084
Pathway	REACTOME_REVERSIBLE_HYDRATION_OF_CARBON_DIOXIDE	CA13 CA3 CA5A CA7	1.08e-06	12	99	4	M671
Pathway	REACTOME_REVERSIBLE_HYDRATION_OF_CARBON_DIOXIDE	CA13 CA3 CA5A CA7	1.08e-06	12	99	4	MM14574
Pathway	KEGG_NITROGEN_METABOLISM	CA13 CA3 CA5A CA7	1.83e-05	23	99	4	M4629
Pubmed	Recurrent NOMO1 Gene Deletion Is a Potential Clinical Marker in Early-Onset Colorectal Cancer and Is Involved in the Regulation of Cell Migration.	NOMO1 NOMO2 NOMO3	7.10e-08	3	145	3	36011023
Pubmed	Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes.	NOMO1 NOMO2 NOMO3	7.10e-08	3	145	3	25576386
Pubmed	A systematic quantification of carbonic anhydrase transcripts in the mouse digestive system.	CA13 CA3 CA5A CA7	1.40e-07	12	145	4	17362527
Pubmed	Evolution of general transcription factors.	GTF2IRD2B GTF2I GTF2IRD2	2.83e-07	4	145	3	23229069
Pubmed	GTF2IRD2 from the Williams-Beuren critical region encodes a mobile-element-derived fusion protein that antagonizes the action of its related family members.	GTF2IRD2B GTF2I GTF2IRD2	2.83e-07	4	145	3	22899722
Pubmed	TFII-I gene family during tooth development: candidate genes for tooth anomalies in Williams syndrome.	GTF2IRD2B GTF2I GTF2IRD2	2.83e-07	4	145	3	17823943
Pubmed	Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology.	NOMO1 NOMO2 NOMO3	2.83e-07	4	145	3	31833031
Pubmed	Haploinsufficiency of Gtf2i, a gene deleted in Williams Syndrome, leads to increases in social interactions.	GTF2IRD2B GTF2I GTF2IRD2	2.83e-07	4	145	3	21328569
Pubmed	A locus for autosomal recessive pseudoxanthoma elasticum, with penetrance of vascular symptoms in carriers, maps to chromosome 16p13.1.	NOMO1 NOMO2 NOMO3	2.83e-07	4	145	3	9267806
Pubmed	FGF21 signalling pathway and metabolic traits - genetic association analysis.	FGFR3 FGFR2 KLB	7.05e-07	5	145	3	20717167
Pubmed	Microtubule associated protein MAP1A is an actin-binding and crosslinking protein.	MAP1A ACTB ACTG1	7.05e-07	5	145	3	7820861
Pubmed	A systematic survey of carbonic anhydrase mRNA expression during mammalian inner ear development.	CA13 CA3 CA5A CA7	2.00e-06	22	145	4	23233153
Pubmed	ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold.	TRPM6 RPN2 ACTB NUP88 ACTG1 ZNF658B NSUN2 GTF2I SSH3 SDHA KLB	3.29e-06	451	145	11	36168627
Pubmed	betaKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c.	FGFR3 FGFR2 KLB	3.91e-06	8	145	3	18187602
Pubmed	Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21.	FGFR3 FGFR2 KLB	3.91e-06	8	145	3	17623664
Pubmed	Carbonic anhydrases in the mouse harderian gland.	CA13 CA3 CA7	3.91e-06	8	145	3	20820888
Pubmed	Nicalin and its binding partner Nomo are novel Nodal signaling antagonists.	NOMO1 NOMO2 NOMO3	3.91e-06	8	145	3	15257293
Pubmed	Substrate-driven assembly of a translocon for multipass membrane proteins.	NOMO1 NOMO2 NOMO3	5.85e-06	9	145	3	36261522
Pubmed	Transmembrane insertases and N-glycosylation critically determine synthesis, trafficking, and activity of the nonselective cation channel TRPC6.	EMC1 NOMO1 NOMO2 SYVN1 NOMO3	6.80e-06	63	145	5	31266804
Pubmed	Hepatic lipase maturation: a partial proteome of interacting factors.	ACTB NOMO1 NOMO2 NOMO3	8.36e-06	31	145	4	19136429
Pubmed	An analysis of expression patterns of genes encoding proteins with catalytic activities.	CA13 SDHA CA3 CA5A CA7	9.22e-06	67	145	5	17626619
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	ZSCAN4 USP24 NUP88 WDR26 GTF2I WDR6 TET1 KDM2B CAMSAP1 ZMYM4	1.10e-05	418	145	10	34709266
Pubmed	N-terminal Slit2 inhibits HIV-1 replication by regulating the actin cytoskeleton.	ACTB ACTG1 SLIT2	1.14e-05	11	145	3	23294842
Pubmed	An ER translocon for multi-pass membrane protein biogenesis.	NOMO1 NOMO2 NOMO3	1.14e-05	11	145	3	32820719
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	EMC1 RPN2 DUSP5 DUSP9 NUP88 PTPRU WDR26 NOMO1 GTF2I WDR6 PREP C3 EIF2A SDHA XPR1	1.48e-05	974	145	15	28675297
Pubmed	Fezl regulates the differentiation and axon targeting of layer 5 subcortical projection neurons in cerebral cortex.	BOC GRB14 PTPRU SLIT2 FGFR3 FGFR2	1.55e-05	126	145	6	16284245
Pubmed	Beta- and gamma-cytoplasmic actins are required for meiosis in mouse oocytes.	ACTB ACTG1	1.73e-05	2	145	2	21778137
Pubmed	Normal immune system development in mice lacking the Deltex-1 RING finger domain.	DTX1 DTX4	1.73e-05	2	145	2	15684394
Pubmed	Functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension.	CYP4A11 CYP4A22	1.73e-05	2	145	2	15611369
Pubmed	De novo mutations in the actin genes ACTB and ACTG1 cause Baraitser-Winter syndrome.	ACTB ACTG1	1.73e-05	2	145	2	22366783
Pubmed	Prenatal presentation and diagnosis of Baraitser-Winter syndrome using exome sequencing.	ACTB ACTG1	1.73e-05	2	145	2	32588558
Pubmed	Baraitser-Winter cerebrofrontofacial syndrome.	ACTB ACTG1	1.73e-05	2	145	2	27625340
Pubmed	Activation of FGF receptors by mutations in the transmembrane domain.	FGFR3 FGFR2	1.73e-05	2	145	2	9136983
Pubmed	Prognostic impact of FGFR2/3 alterations in patients with biliary tract cancers receiving systemic chemotherapy: the BITCOIN study.	FGFR3 FGFR2	1.73e-05	2	145	2	35303508
Pubmed	RIM2α is a molecular scaffold for Zona pellucida-induced acrosome reaction.	RIMS1 RIMS2	1.73e-05	2	145	2	25240052
Pubmed	Androgen-sensitive hypertension associates with upregulated vascular CYP4A12-20-HETE synthase.	CYP4A11 CYP4A22	1.73e-05	2	145	2	23641057
Pubmed	The Blood Pressure-Lowering Effect of 20-HETE Blockade in Cyp4a14(-/-) Mice Is Associated with Natriuresis.	CYP4A11 CYP4A22	1.73e-05	2	145	2	28912346
Pubmed	Altered inflammatory responses to Citrobacter rodentium infection, but not bacterial lipopolysaccharide, in mice lacking the Cyp4a10 or Cyp4a14 genes.	CYP4A11 CYP4A22	1.73e-05	2	145	2	24413902
Pubmed	Rapidly acquired resistance to EGFR tyrosine kinase inhibitors in NSCLC cell lines through de-repression of FGFR2 and FGFR3 expression.	FGFR3 FGFR2	1.73e-05	2	145	2	21152424
Pubmed	Isolation of cDNA clones for mouse cytoskeletal gamma-actin and differential expression of cytoskeletal actin mRNAs in mouse cells.	ACTB ACTG1	1.73e-05	2	145	2	3221869
Pubmed	ACTB and SDHA Are Suitable Endogenous Reference Genes for Gene Expression Studies in Human Astrocytomas Using Quantitative RT-PCR.	ACTB SDHA	1.73e-05	2	145	2	30259794
Pubmed	Deduced amino acid sequence of a murine cytochrome P-450 Cyp4a protein: developmental and hormonal regulation in liver and kidney.	CYP4A11 CYP4A22	1.73e-05	2	145	2	8031839
Pubmed	Human fatty acid omega-hydroxylase, CYP4A11: determination of complete genomic sequence and characterization of purified recombinant protein.	CYP4A11 CYP4A22	1.73e-05	2	145	2	10860550
Pubmed	Analysis of RIM Expression and Function at Mouse Photoreceptor Ribbon Synapses.	RIMS1 RIMS2	1.73e-05	2	145	2	28701482
Pubmed	TET1 suppresses colon cancer proliferation by impairing β-catenin signal pathway.	AXIN1 TET1	1.73e-05	2	145	2	30825236
Pubmed	Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension.	CYP4A11 CYP4A22	1.73e-05	2	145	2	11320253
Pubmed	Measurements of spatiotemporal changes in G-actin concentration reveal its effect on stimulus-induced actin assembly and lamellipodium extension.	ACTB ACTG1	1.73e-05	2	145	2	21502360
Pubmed	Germline mutations in FGF receptors and medulloblastomas.	FGFR3 FGFR2	1.73e-05	2	145	2	23325524
Pubmed	The evolution and complexity of the genes encoding the cytoskeletal proteins of human epidermal cells.	ACTB ACTG1	1.73e-05	2	145	2	6686106
Pubmed	RIM C2B Domains Target Presynaptic Active Zone Functions to PIP2-Containing Membranes.	RIMS1 RIMS2	1.73e-05	2	145	2	29606581
Pubmed	Actin amino-acid sequences. Comparison of actins from calf thymus, bovine brain, and SV40-transformed mouse 3T3 cells with rabbit skeletal muscle actin.	ACTB ACTG1	1.73e-05	2	145	2	213279
Pubmed	The First Korean Case of Baraitser-Winter Cerebro-Fronto-Facial Syndrome with a Novel Mutation in ACTB Diagnosed Via Targeted Gene Panel Sequencing and Literature Review.	ACTB ACTG1	1.73e-05	2	145	2	33334799
Pubmed	Characterization of the CYP4A11 gene, a second CYP4A gene in humans.	CYP4A11 CYP4A22	1.73e-05	2	145	2	12464262
Pubmed	β-Actin specifically controls cell growth, migration, and the G-actin pool.	ACTB ACTG1	1.73e-05	2	145	2	21900491
Pubmed	RIM1/2-Mediated Facilitation of Cav1.4 Channel Opening Is Required for Ca2+-Stimulated Release in Mouse Rod Photoreceptors.	RIMS1 RIMS2	1.73e-05	2	145	2	26400943
Pubmed	Inhibitor-sensitive FGFR2 and FGFR3 mutations in lung squamous cell carcinoma.	FGFR3 FGFR2	1.73e-05	2	145	2	23786770
Pubmed	Expression of cytochrome P450 4A mRNA in mouse lung: effect of clofibrate and interleukin-1beta.	CYP4A11 CYP4A22	1.73e-05	2	145	2	15066132
Pubmed	Beta and gamma-cytoplasmic actins display distinct distribution and functional diversity.	ACTB ACTG1	1.73e-05	2	145	2	19638415
Pubmed	Botulinum C2 toxin ADP-ribosylates cytoplasmic beta/gamma-actin in arginine 177.	ACTB ACTG1	1.73e-05	2	145	2	3335520
Pubmed	Fibroblast growth factor receptor 3 is a negative regulator of bone growth.	FGFR3 FGFR2	1.73e-05	2	145	2	8601314
Pubmed	Association of human immunodeficiency virus Nef protein with actin is myristoylation dependent and influences its subcellular localization.	ACTB ACTG1	1.73e-05	2	145	2	9288906
Pubmed	WDR26 is a new partner of Axin1 in the canonical Wnt signaling pathway.	WDR26 AXIN1	1.73e-05	2	145	2	27098453
Pubmed	High level expression of transfected beta- and gamma-actin genes differentially impacts on myoblast cytoarchitecture.	ACTB ACTG1	1.73e-05	2	145	2	1577857
Pubmed	A presynaptic phosphosignaling hub for lasting homeostatic plasticity.	RIMS1 RIMS2	1.73e-05	2	145	2	35443170
Pubmed	20-HETE induces remodeling of renal resistance arteries independent of blood pressure elevation in hypertension.	CYP4A11 CYP4A22	1.73e-05	2	145	2	23825080
Pubmed	Salt-sensitive hypertension is associated with dysfunctional Cyp4a10 gene and kidney epithelial sodium channel.	CYP4A11 CYP4A22	1.73e-05	2	145	2	16691295
Pubmed	The P450 gene superfamily: recommended nomenclature.	CYP4A11 CYP4A22	1.73e-05	2	145	2	3829886
Pubmed	Novel targetable FGFR2 and FGFR3 alterations in glioblastoma associate with aggressive phenotype and distinct gene expression programs.	FGFR3 FGFR2	1.73e-05	2	145	2	33853673
Pubmed	Baraitser-Winter Cerebrofrontofacial Syndrome	ACTB ACTG1	1.73e-05	2	145	2	26583190
Pubmed	Knockout of ACTB and ACTG1 with CRISPR/Cas9(D10A) Technique Shows that Non-Muscle β and γ Actin Are Not Equal in Relation to Human Melanoma Cells' Motility and Focal Adhesion Formation.	ACTB ACTG1	1.73e-05	2	145	2	32326615
Pubmed	Induction of cytochrome P450 4A14 contributes to angiotensin II-induced renal fibrosis in mice.	CYP4A11 CYP4A22	1.73e-05	2	145	2	29277328
Pubmed	Genetic polymorphism of CYP4A11 and CYP4A22 genes and in silico insights from comparative 3D modelling in a French population.	CYP4A11 CYP4A22	1.73e-05	2	145	2	21820496
Pubmed	Severe forms of Baraitser-Winter syndrome are caused by ACTB mutations rather than ACTG1 mutations.	ACTB ACTG1	1.73e-05	2	145	2	23756437
Pubmed	Early mandibular morphological differences in patients with FGFR2 and FGFR3-related syndromic craniosynostoses: A 3D comparative study.	FGFR3 FGFR2	1.73e-05	2	145	2	32822871
Pubmed	Renal function and vasomotor activity in mice lacking the Cyp4a14 gene.	CYP4A11 CYP4A22	1.73e-05	2	145	2	20943934
Pubmed	Cytochalasin D-induced actin gene expression in murine erythroleukemia cells.	ACTB ACTG1	1.73e-05	2	145	2	8482333
Pubmed	The rat clofibrate-inducible CYP4A subfamily. II. cDNA sequence of IVA3, mapping of the Cyp4a locus to mouse chromosome 4, and coordinate and tissue-specific regulation of the CYP4A genes.	CYP4A11 CYP4A22	1.73e-05	2	145	2	2766933
Pubmed	Impaired muscle relaxation and mitochondrial fission associated with genetic ablation of cytoplasmic actin isoforms.	ACTB ACTG1	1.73e-05	2	145	2	29265728
Pubmed	Multi-isotope imaging mass spectrometry reveals slow protein turnover in hair-cell stereocilia.	ACTB ACTG1	1.73e-05	2	145	2	22246323
Pubmed	RIM genes differentially contribute to organizing presynaptic release sites.	RIMS1 RIMS2	1.73e-05	2	145	2	22753485
Pubmed	Structure, chromosome location, and expression of the human gamma-actin gene: differential evolution, location, and expression of the cytoskeletal beta- and gamma-actin genes.	ACTB ACTG1	1.73e-05	2	145	2	2837653
Pubmed	Prevalence of Cytoplasmic Actin Mutations in Diffuse Large B-Cell Lymphoma and Multiple Myeloma: A Functional Assessment Based on Actin Three-Dimensional Structures.	ACTB ACTG1	1.73e-05	2	145	2	32349449
Pubmed	Baraitser-Winter cerebrofrontofacial syndrome: Report of two adult siblings.	ACTB ACTG1	1.73e-05	2	145	2	32506774
Pubmed	Mutations in fibroblast growth factor receptor 2 and fibroblast growth factor receptor 3 genes associated with human gastric and colorectal cancers.	FGFR3 FGFR2	1.73e-05	2	145	2	11325814
Pubmed	Differential arginylation of actin isoforms is regulated by coding sequence-dependent degradation.	ACTB ACTG1	1.73e-05	2	145	2	20847274
Pubmed	Mouse Cyp4a isoforms: enzymatic properties, gender- and strain-specific expression, and role in renal 20-hydroxyeicosatetraenoic acid formation.	CYP4A11 CYP4A22	1.73e-05	2	145	2	17112342
Pubmed	Comparison of TFII-I gene family members deleted in Williams-Beuren syndrome.	GTF2IRD2B GTF2IRD2	1.73e-05	2	145	2	15388857
Pubmed	High-fat diet-induced obesity and insulin resistance in CYP4a14-/- mice is mediated by 20-HETE.	CYP4A11 CYP4A22	1.73e-05	2	145	2	30088983
Pubmed	The presynaptic active zone protein RIM1α controls epileptogenesis following status epilepticus.	RIMS1 RIMS2	1.73e-05	2	145	2	22956829
Pubmed	Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases.	CYP4A11 CYP4A22	1.73e-05	2	145	2	19208908
Pubmed	An FGFR1-SPRY2 Signaling Axis Limits Basal Cell Proliferation in the Steady-State Airway Epithelium.	ACTB FGFR3 FGFR2	3.11e-05	15	145	3	27046834
Pubmed	Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability.	ACTB PON1 ACTG1 C1R C3 EIF2A	3.16e-05	143	145	6	22516433
Pubmed	Genome duplications and other features in 12 Mb of DNA sequence from human chromosome 16p and 16q.	NOMO1 DOK4 NOMO2 NOMO3 CA7	4.32e-05	92	145	5	10493829
Pubmed	The cleavage of host cell proteins by HIV-1 protease.	MAP1A ACTB ACTG1	4.62e-05	17	145	3	8997639
Pubmed	Transient Redirection of SVZ Stem Cells to Oligodendrogenesis by FGFR3 Activation Promotes Remyelination.	FGFR3 FGFR2	5.16e-05	3	145	2	31189094
Pubmed	Molecular characterization of abLIM, a novel actin-binding and double zinc finger protein.	ACTB ACTG1	5.16e-05	3	145	2	9245787
Pubmed	Genetic analysis of resistance to radiation lymphomagenesis with recombinant inbred strains of mice.	CYP4A11 CYP4A22	5.16e-05	3	145	2	2354437
Pubmed	Impact of altered actin gene expression on vinculin, talin, cell spreading, and motility.	ACTB ACTG1	5.16e-05	3	145	2	7646816
Pubmed	Isolation of the complementary DNA encoding a mouse heparin-binding growth factor receptor with the use of a unique kinase insert sequence.	FGFR3 FGFR2	5.16e-05	3	145	2	8382556
Pubmed	Angiostatin and plasminogen share binding to endothelial cell surface actin.	ACTB ACTG1	5.16e-05	3	145	2	15746964
GeneFamily	Carbonic anhydrases	CA13 CA3 CA5A CA7	2.44e-06	18	99	4	460
GeneFamily	Regulating synaptic membrane exocytosis family\|PDZ domain containing	RIMS1 RIMS2	1.77e-04	4	99	2	833
GeneFamily	Fibronectin type III domain containing	CHL1 BOC OBSCN PTPRU PTPRT USH2A	2.49e-04	160	99	6	555
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	CHL1 BOC OBSCN PXDNL FGFR3 FGFR2	2.57e-04	161	99	6	593
GeneFamily	Actins	ACTB ACTG1	4.39e-04	6	99	2	929
GeneFamily	MAP kinase phosphatases	DUSP5 DUSP9	1.58e-03	11	99	2	895
GeneFamily	Zinc fingers CXXC-type	TET1 KDM2B	1.89e-03	12	99	2	136
GeneFamily	WD repeat domain containing	WDR81 WDR26 TBC1D31 WDR6 WDR87 WDR17	3.19e-03	262	99	6	362
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	WDR81 AXIN1 YLPM1 SPRED1 PPP1R36	3.19e-03	181	99	5	694
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	PAMR1 C1R SEZ6L	3.76e-03	57	99	3	1179
GeneFamily	Protein tyrosine phosphatases, receptor type	PTPRU PTPRT	5.82e-03	21	99	2	813
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_basal-Basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DUSP9 OBSCN EPB41L4A PTPRT SYT8 FGFR3 FGFR2 XPR1	2.59e-07	195	145	8	6c9c58322c1df891bb4bab56dacb542c8777bb7d
ToppCell	P15-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CHL1 DPY19L3 DCK ARMC2 ZNF23 SPRED1 MAST3	1.82e-06	176	145	7	792f414f5092aba14260b8e16378e793a822498e
ToppCell	Adult-Epithelial-basal_cell\|Adult / Lineage, Cell type, age group and donor	CHL1 CCDC60 EPB41L4A SYT8 FGFR3 FGFR2 XPR1	2.36e-06	183	145	7	00a6b19ca49e3b8e0d1cd387a3515b0ff4b81c81
ToppCell	facs-Skin-Anagen-3m-Epithelial-nan\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 GALNT1 RPN2 CA13 NSUN2 LIPM PREP	2.63e-06	186	145	7	9a7932d0a208f3997216bd21a72913cc82b59fc9
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CHL1 TRPM6 OBSCN ACTG1 PTPRT PGAP1 FGFR3	3.97e-06	198	145	7	5374b0e98d669f36a0571d3c006c7bd5e3c8e87f
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GALNT1 PAMR1 CA13 NEB SLIT2 SYVN1	1.94e-05	169	145	6	16c52a0f6d96ecc1832922fce9b39691849f0d73
ToppCell	TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-6\|TCGA-Liver / Sample_Type by Project: Shred V9	BOC PDE1B MAP1A C16orf89 SLIT2 WDR17	1.94e-05	169	145	6	e992530776cab922d0360b275fb9cb8bd0017b06
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-stromal_related\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BOC PAMR1 PTPRU C16orf89 C1R C3	2.36e-05	175	145	6	b8995e7ada85ba959f06264a0295b61e390c4e6c
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-stromal_related-T_reticular\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BOC PAMR1 PTPRU C16orf89 C1R C3	2.36e-05	175	145	6	7ae76bd3b4f610b2f98716a4456437cd3696b686
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BOC PDE1B OBSCN ATP10D SLIT2 C1R	2.52e-05	177	145	6	bd602db857f37869ef76d14c05ef522c509f08ee
ToppCell	nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CHL1 PTPRU EPB41L4A FGFR3 FGFR2 XPR1	2.52e-05	177	145	6	cbad1a23851151dbef01ea2af960e6f0944f838b
ToppCell	nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Basal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CHL1 PTPRU EPB41L4A FGFR3 FGFR2 XPR1	2.52e-05	177	145	6	ce86dfaeb74d995a19aea62f0fb15c4c0bb854b0
ToppCell	COVID-19_Convalescent-PLT_1\|World / Disease Group and Platelet Clusters	EMC1 NOMO2 YLPM1 GTF2IRD2 CRYZL1 SYVN1	2.68e-05	179	145	6	d0f2764c6fc5d61fd69e9231b3603a80ac373f65
ToppCell	tumor_Lymph_Node_/_Brain-Myeloid_cells-Activated_DCs\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	MAN1A1 DUSP5 ACTB RUBCN SEZ6L CA5A	2.77e-05	180	145	6	aae85fb3c92a45614616a3ee3a1af5244cc299a7
ToppCell	3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BOC PAMR1 C16orf89 SLIT2 C1R C3	2.85e-05	181	145	6	e1ae9ada60ec89e7a7cde9c231c1a099ed2ffecc
ToppCell	Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_1\|Thalamus / BrainAtlas - Mouse McCarroll V32	RAB19 TLR6 C16orf89 GVINP1 CA5A	2.89e-05	109	145	5	4e4a884b8979f4ff8b232c1581ea78884dda29ed
ToppCell	facs-Skin-Telogen-3m-Epithelial-epidermal_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 GALNT1 TRIM16 DOK4 LIPM EEF2K	3.04e-05	183	145	6	ed1e0b07475f9951728682ed70b85367cf2a744d
ToppCell	metastatic_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_LZ\|metastatic_Lymph_Node / Location, Cell class and cell subclass	DTX1 ACTB ACTG1 TCL1A SEMA4A SYVN1	3.04e-05	183	145	6	30db83f600e2c4ad3af68a8a946673f4352a2807
ToppCell	COVID-19-Epithelial_cells-Airway_basal\|COVID-19 / group, cell type (main and fine annotations)	TRPM6 EPB41L4A SYT8 FGFR3 FGFR2 XPR1	3.43e-05	187	145	6	8407a82e98f56a94ea26562bcb6bbe00a8f41661
ToppCell	343B-Lymphocytic-ILC-ILC-1\|343B / Donor, Lineage, Cell class and subclass (all cells)	NSUN2 AXIN1 ARL5B TBC1D31 POLR3E TET1	3.53e-05	188	145	6	8f6b45ad82bde65e044d17f0edbc3db90d457915
ToppCell	COPD-Endothelial-VE_Arterial\|Endothelial / Disease state, Lineage and Cell class	CHL1 GRB14 TIPARP NOMO1 NOMO2 NOMO3	3.86e-05	191	145	6	ef16ad1c1cd2c0c0377957398c98775b62a81754
ToppCell	IPF-Epithelial-Goblet\|Epithelial / Disease state, Lineage and Cell class	CHL1 DUSP5 C16orf89 C3 RIMS1 FGFR2	3.86e-05	191	145	6	267e1192aaec468c1a59eb24848b37e0e18cbc44
ToppCell	5'-Adult-LymphNode-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BOC HIC1 TIPARP C16orf89 C1R C3	3.97e-05	192	145	6	9479e9859140ba98abfe88414de0b28fc2bf43b7
ToppCell	RV-01._Fibroblast_I\|RV / Chamber and Cluster_Paper	MAN1A1 PAMR1 XYLT1 SLIT2 C1R C3	3.97e-05	192	145	6	356160b113c3305a61ceeaff33ce3c9da0be2878
ToppCell	facs-Skin-Anagen-3m-Epithelial-basal_cell_of_epidermis\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 RPN2 NSUN2 TIPARP PREP FGFR2	3.97e-05	192	145	6	ec1fd2fb6e71f87189d66261909a84e2be63cacb
ToppCell	5'-Adult-LymphNode-Mesenchymal-fibroblastic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BOC HIC1 TIPARP C16orf89 C1R C3	3.97e-05	192	145	6	d7faa993f68e530ad55185505384ae155d36c222
ToppCell	COPD-Epithelial-Goblet\|COPD / Disease state, Lineage and Cell class	CHL1 FA2H PTPRU C16orf89 RIMS1 FGFR2	3.97e-05	192	145	6	93b2ca0a97776d28c7e8f1a0642c4b63a5554aab
ToppCell	11.5-Airway-Mesenchymal-Cartilage\|Airway / Age, Tissue, Lineage and Cell class	BOC DUSP9 XYLT1 SYT8 FGFR3 FGFR2	4.09e-05	193	145	6	d4779d92a4dd4b8b656383e6f4fce76d3bd70931
ToppCell	droplet-Pancreas-Endocrine-21m\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RPN2 ACTB ACTG1 NEB WDR6 ABCC8	4.21e-05	194	145	6	3a3ecedcdc7691cf21775818b598208fcb980c29
ToppCell	NS-critical-d_07-13-Epithelial-Secretory\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CHL1 DTX4 C3 FGFR3 RIMS1 FGFR2	4.21e-05	194	145	6	2172d951896265243d14996eacce5aab5e14e26e
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRPM6 MAN1A1 DUSP9 USP24 GRB14 GTF2I	4.33e-05	195	145	6	a38d9dc6192aea673d96fda6b25e81223fda3abf
ToppCell	Healthy-B_intermediate\|World / disease group, cell group and cell class	CHL1 BOC DTX1 NEB PTPRT TCL1A	4.33e-05	195	145	6	9de79e0bdd9063ae65e5edb89cc3fe6f9a8173bc
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW09-Macroglial-Glia_progenitor_cell\|GW09 / Sample Type, Dataset, Time_group, and Cell type.	DPY19L3 POLR3E GTF2IRD2 TRPM8 FGFR3 SEMA4A	4.45e-05	196	145	6	7be50b9156394dea44d7b8b476d4dd516abfafae
ToppCell	distal-mesenchymal-Lipofibroblast-1\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	BOC PAMR1 SLIT2 PGAP1 C1R C3	4.58e-05	197	145	6	865010edcd7e3f79f505fcef7b33882095994aa8
ToppCell	distal-mesenchymal-Lipofibroblast\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	BOC PAMR1 SLIT2 PGAP1 C1R C3	4.58e-05	197	145	6	ceb83bdef16b58ee16193413bfb006f7715728b2
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	EPB41L4A PTPRT SYT8 FGFR3 FGFR2 XPR1	4.58e-05	197	145	6	107cb153ea7fc74bbd244dbb9d0499c0a8506724
ToppCell	COVID_vent-Lymphocytic-Plasma_cell-IgA_Plasmablast\|COVID_vent / Disease condition, Lineage, Cell class and subclass	MAN1A1 RPN2 NOMO1 NOMO2 SYVN1 NOMO3	4.58e-05	197	145	6	99fe44ef42c65d24fe64947fd5bf6d91b9a4b2c3
ToppCell	NS-critical-d_16-33-Epithelial-Secretory\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CHL1 DTX4 C3 FGFR3 RIMS1 FGFR2	4.58e-05	197	145	6	a72047b7428c0d4aaf016c1ac23dc30919260fd8
ToppCell	367C-Fibroblasts-Fibroblast-E-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	BOC CYP27A1 TIPARP C16orf89 C1R C3	4.85e-05	199	145	6	2aed8f4a225a3762a5e7ce99aacad9b2a37d61f1
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CHL1 TRPM6 OBSCN PTPRT PGAP1 FGFR3	4.85e-05	199	145	6	94a7867e800df352731796de8c24cba133c29622
ToppCell	367C-Fibroblasts-Fibroblast-E\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	BOC CYP27A1 TIPARP C16orf89 C1R C3	4.85e-05	199	145	6	c40ca26345753a2197bd9389d7323f7491c1e11d
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CHL1 USP24 PTPRT XYLT1 ABCC8 SEZ6L	4.85e-05	199	145	6	333056c2abe9724efeab542c0365fcfe4eff8f18
ToppCell	NS-control-d_0-4-Epithelial-Secretory\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CHL1 DTX4 C3 FGFR3 RIMS1 FGFR2	4.85e-05	199	145	6	32bdfff40fd442b88489c8b0f79af3927a51a03c
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CHL1 USP24 PTPRT XYLT1 ABCC8 SEZ6L	4.85e-05	199	145	6	19a97e27a4758e794ce7246d295e112b47931a48
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CHL1 USP24 PTPRT XYLT1 ABCC8 SEZ6L	4.85e-05	199	145	6	e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698
ToppCell	control-Epithelial-Secretory\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CHL1 DTX4 C3 FGFR3 RIMS1 FGFR2	4.85e-05	199	145	6	262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a
ToppCell	distal-1-mesenchymal-Lipofibroblast\|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	BOC PAMR1 SLIT2 PGAP1 C1R C3	4.85e-05	199	145	6	a8293db3c42a8d30897858b49aae7acfc18663ba
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW08-Mesenchymal\|GW08 / Sample Type, Dataset, Time_group, and Cell type.	BOC LRRC8C CA13 DNAJC22 SYVN1 MAST3	4.98e-05	200	145	6	e5b7d9622b96bb20c81ac76b4e60e8b44fa9cca1
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Car3\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	CA13 PTPRU LIPM IQGAP3 CA3	7.76e-05	134	145	5	4ef5f395e321cf04e56560be2502a8aa157682f4
ToppCell	Control-Plasmablast\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	MAN1A1 RPN2 NOMO1 NOMO2 SEMA4A	1.13e-04	145	145	5	fe68582f5a15b9714cb84fa32ac880e13cb69895
ToppCell	Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Gkn3_(Gkn3)--\|Thalamus / BrainAtlas - Mouse McCarroll V32	RAB19 TLR6 GVINP1 CA5A	1.17e-04	77	145	4	9743d4a79c8694f76ab780b9e52b4c6ac1af33ed
ToppCell	Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Gkn3_(Gkn3)-\|Thalamus / BrainAtlas - Mouse McCarroll V32	RAB19 TLR6 GVINP1 CA5A	1.17e-04	77	145	4	22e8c486ad82773b1facd8dd55ed3f448612c600
ToppCell	Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Gkn3_(Gkn3)\|Thalamus / BrainAtlas - Mouse McCarroll V32	RAB19 TLR6 GVINP1 CA5A	1.17e-04	77	145	4	7e30a46aa68a9374c4c99385a383e0865ff45b1c
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	NOMO1 C16orf89 SPRED1 RIMS2 NOMO3	1.45e-04	153	145	5	4eb9c2d7e4b95d44198fc87dc115a08ef0153e26
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_ILC-NK_cell\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	NOMO1 C16orf89 SPRED1 RIMS2 NOMO3	1.45e-04	153	145	5	26b5b45c117d155b028d298a0b93e16d343dca97
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_ILC\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	NOMO1 C16orf89 SPRED1 RIMS2 NOMO3	1.45e-04	153	145	5	0f12e38f2cbf69a520764289b0aa4dedc645f714
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial-astrocyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DPY19L3 DTX1 GRIN2C ABCC8 FGFR3	1.49e-04	154	145	5	5ed64bbf603290e6dc34f81d145982690b89dd0d
ToppCell	Children_(3_yrs)-Epithelial-basal_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TRPM6 EPB41L4A SYT8 WDR87 FGFR2	1.63e-04	157	145	5	6ee2692f705bdd93ba523dffaf2f0cd921b47e28
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CHL1 DUSP5 C3 RIMS1 FGFR2	1.73e-04	159	145	5	60b1f4dce2ce0911160fda17f137c064da31e2eb
ToppCell	LAM-Lymphoid-pDC\|LAM / Condition, Lineage and Cell class	MAP1A DUSP5 DCK TCL1A RUBCN	1.83e-04	161	145	5	bb5b44713e4da4406cdaa79dcf2aa9f97e3cf75a
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	DPY19L3 DUSP5 OBSCN ABCC8 CA7	1.94e-04	163	145	5	218b9ba099cb27aa91c6b73bf89b44895f5dddc3
ToppCell	Club-club-12\|World / Class top	PON1 C16orf89 ABCC8 C3 CA5A	2.06e-04	165	145	5	9b7a31cbdcd2f96b8bd08a4cd4141b92bd5e9062
ToppCell	LPS-antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PAMR1 FA2H SYT8 C3	2.23e-04	91	145	4	b0658e020f80e56fab9d2aa07e321d9b33d7af2c
ToppCell	3'-Child09-12-SmallIntestine-Hematopoietic-B_cells-LZ_GC_cell\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ACTB ACTG1 TCL1A SEMA4A SYVN1	2.24e-04	168	145	5	08eb1284f9b8bd3e0e4b21bfc2bbee01d35a0bd7
ToppCell	LPS-antiTNF-Epithelial_alveolar-Mes-Like\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ADAM7 ACTB RAB39B USH2A	2.42e-04	93	145	4	93a8d3ad978e4cd450f7a69a4cbac1a59038e80d
ToppCell	facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRU LIPM ABCC8 C3 IQGAP3	2.43e-04	171	145	5	913bae728b5e653771a27c79a309eb023699f1d0
ToppCell	Control-Epithelial_cells-Airway_basal\|Control / group, cell type (main and fine annotations)	CHL1 TRPM6 EPB41L4A FGFR3 FGFR2	2.43e-04	171	145	5	3965ced4be6db14265a90673502fceee425837ca
ToppCell	facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRU LIPM ABCC8 C3 IQGAP3	2.43e-04	171	145	5	f28b2336057e353b96a6ff4581ec9fd0ca0789d9
ToppCell	facs-Lung-24m-Epithelial-airway_epithelial-club_cell-club_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FA2H CA13 SYT8 RAB39B CA3	2.43e-04	171	145	5	8ed98f223143bd81d9819e9a420eb9cc81ee6c53
ToppCell	facs-Lung-24m-Epithelial-airway_epithelial-club_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FA2H CA13 SYT8 RAB39B CA3	2.43e-04	171	145	5	bd339e482f09a3fa04b086029b94f45205b8a6c5
ToppCell	3'-Adult-Distal_Rectal-Epithelial-Tuft-related-BEST4+_epithelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	EPB41L4A ARL5B PPP1R36 CA5A CA7	2.43e-04	171	145	5	317b70d72a4ca5336cfb6a49dc57f8e2a8a1c736
ToppCell	wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_2\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	CHL1 C16orf89 C3 FGFR3 RIMS1	2.56e-04	173	145	5	d1e47c87bd4750801f3531f66a56c5dccb4ea64c
ToppCell	Adult-Epithelial-basal_cell-D231\|Adult / Lineage, Cell type, age group and donor	CHL1 EPB41L4A SYT8 WDR87 XPR1	2.63e-04	174	145	5	a4f98afe7d1cc2617f6f7bc8092c41df57474b30
ToppCell	15-Trachea-Mesenchymal-Mesenchyme_RSPO2+\|Trachea / Age, Tissue, Lineage and Cell class	TRPM8 FGFR3 FGFR2 SEMA4A IQGAP3	2.63e-04	174	145	5	fa0681e91724b9a51ee28b214ea5aa14e62ba1a3
ToppCell	ASK452-Immune-B_cell\|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq	CCDC60 DUSP5 CA13 PTPRU TCL1A	2.63e-04	174	145	5	69723f5666abc3af5f0431901a60246c9915ef81
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BOC PAMR1 TIPARP C1R C3	2.63e-04	174	145	5	9c916af5eebd932f67dc9117e1d26ff194a2ff2c
ToppCell	TCGA-Liver\|World / Sample_Type by Project: Shred V9	CYP4A11 PON1 CYP4A22 CA5A KLB	2.63e-04	174	145	5	452932f08cf53e5949672a025d78cecb874aa4b0
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BOC PAMR1 TIPARP C1R C3	2.63e-04	174	145	5	bc71521f44a5fe013af42b06b5d1bd2446ecf3b5
ToppCell	3'-GW_trimst-1-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ABO FA2H PREP CA3 CA7	2.70e-04	175	145	5	8727252bcbc70bfa2ff72e7421df9cfe6fd4eed7
ToppCell	TCGA-Colorectal-Recurrent_Tumor\|TCGA-Colorectal / Sample_Type by Project: Shred V9	CYP4A11 PON1 CYP4A22 TRPM8 CA5A	2.70e-04	175	145	5	7f74961436f88c0e380819095e6104489914d765
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ABO TEX15 PTPRU NPFFR2 SEMA4A	2.70e-04	175	145	5	90e29945aa861082c94bb4f331161adc3a6ef899
ToppCell	COVID-19_Convalescent\|World / Disease Group and Platelet Clusters	LRRC8C EMC1 NOMO2 GTF2IRD2 SECISBP2	2.70e-04	175	145	5	e9b1faa4c85537f30306619a2f3ada6c8ef0ac6c
ToppCell	TCGA-Colorectal-Recurrent_Tumor-Colorectal_Adenocarcinoma\|TCGA-Colorectal / Sample_Type by Project: Shred V9	CYP4A11 PON1 CYP4A22 TRPM8 CA5A	2.70e-04	175	145	5	bee8f31f036dfcf9fc6ed29156554771a9ee3c60
ToppCell	(03)_Secretory-(4)_1wkpi\|(03)_Secretory / shred by cell type and Timepoint	MAN1A1 GALNT1 PON1 EEF2K FGFR3	2.70e-04	175	145	5	06b52f85baa31b55bb31477244892b6da79fe2c9
ToppCell	3'-GW_trimst-1-LargeIntestine-Epithelial-Tuft-related\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ABO FA2H PREP CA3 CA7	2.70e-04	175	145	5	c083abe368e5c0dc2b0f27f375c9271a2d7ff64f
ToppCell	pdx-Tumor_cells-T2\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	CA13 GYG2 CA3 CA5A KLB	2.77e-04	176	145	5	1e21f80cf0e695ffdd63e4a72cf1e3fa41b60341
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ABO TEX15 PTPRU NPFFR2 SEMA4A	2.77e-04	176	145	5	e4b21fd6a5e0c5950f27c3e1868318e48330ae5e
ToppCell	facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ZNF23 TBC1D31 ABCC8 RAB39B SEZ6L	2.84e-04	177	145	5	8abdf1d970b2f15e17e185f3e612dd5065c88757
ToppCell	343B-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2\|343B / Donor, Lineage, Cell class and subclass (all cells)	HIC1 CNBD2 EPB41L4A TBC1D31 POLR3E	2.92e-04	178	145	5	5289ac61637224ae70ffbc2d164d73116f10af40
ToppCell	droplet-Heart-4Chambers-21m-Mesenchymal-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE1B MAP1A TLR6 ARMC2 CA3	3.00e-04	179	145	5	b44e2d53b82c3c141bfc6539054b19708200a0d9
ToppCell	ASK452-Immune-B_cell\|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq	CCDC60 DUSP5 CA13 PTPRU TCL1A	3.00e-04	179	145	5	c3cf49c069e66db16d2fce1de4c52a4c4fe7e832
ToppCell	Epithelial-basal_cell\|World / Lineage, Cell type, age group and donor	TRPM6 EPB41L4A SYT8 FGFR2 XPR1	3.00e-04	179	145	5	d9be6647ec7b22747dc00dce4ea307b6af412dfa
ToppCell	NS-moderate-d_16-33-Myeloid-pDC\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	MAP1A DUSP5 DCK TCL1A RUBCN	3.07e-04	180	145	5	144818e69613296cde43f29cb8c20899c670b319
ToppCell	Control-Epithelial-Goblet\|Control / Disease state, Lineage and Cell class	CHL1 C16orf89 FGFR3 RIMS1 FGFR2	3.07e-04	180	145	5	5293d23b8b8ea587239ffde561b70bad01632521
ToppCell	moderate-Myeloid-pDC\|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	MAP1A DUSP5 DCK TCL1A RUBCN	3.07e-04	180	145	5	1d8df7df03a71f49d6683554d3c948ce90dda42e
ToppCell	droplet-Lung-LUNG-1m-Epithelial-type_II_pneumocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PON1 GRB14 TEX15 ZNF23 FGFR2	3.23e-04	182	145	5	c1e0be27064e14043b78ae501b02d4e9542267a3
ToppCell	TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Epitheliod\|TCGA-Mesothelium / Sample_Type by Project: Shred V9	TRAF3IP2 DOK4 SSH3 C1R C3	3.23e-04	182	145	5	bb1f815718397de96682697fcbd6014a992a28f7
ToppCell	droplet-Lung-LUNG-1m-Epithelial-Alveolar_Epithelial_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PON1 GRB14 TEX15 ZNF23 FGFR2	3.23e-04	182	145	5	3c9b4869d357884ae4bcd22a9872faf83a5cfc6d
ToppCell	facs-Skin-Telogen-3m-Epithelial-nan\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 CA13 TIPARP TRIM16 LIPM	3.31e-04	183	145	5	26b18d1cc5d98f185176e100bafb9bc9081c66f7
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CHL1 BOC DTX1 NEB PTPRT	3.31e-04	183	145	5	01664fce6b70a02c9d39d747b6a6aabc86d57bc2
Drug	Fg 400	BOC CA13 CA3 CA5A CA7	1.17e-08	13	144	5	CID000012443
Drug	metolazone	CA13 SLC6A7 CA3 CA5A CA7	5.49e-08	17	144	5	CID000004170
Drug	aminozolamide	CA13 CA3 CA5A CA7	1.05e-07	8	144	4	CID000093505
Drug	L-662,583	CA13 CA3 CA5A CA7	1.05e-07	8	144	4	CID003082977
Drug	L-643,799	CA13 CA3 CA5A CA7	1.05e-07	8	144	4	CID000121595
Drug	sezolamide	CA13 CA3 CA5A CA7	1.05e-07	8	144	4	CID000060692
Drug	qassa	CA13 CA3 CA5A CA7	1.89e-07	9	144	4	CID003082191
Drug	6-hydroxyethoxzolamide	CA13 CA3 CA5A CA7	1.89e-07	9	144	4	CID000094706
Drug	Prontosil	CA13 CA3 CA5A CA7	3.13e-07	10	144	4	CID000066895
Drug	metanilamide	CA13 CA3 CA5A CA7	3.13e-07	10	144	4	CID000007377
Drug	1,3-benzenedisulfonamide	CA13 CA3 CA5A CA7	3.13e-07	10	144	4	CID003090044
Drug	Cl 13850	CA13 CA3 CA5A CA7	4.89e-07	11	144	4	CID000159459
Drug	cobalt phosphate	CA13 CA3 CA5A CA7	4.89e-07	11	144	4	CID000061615
Drug	Tio-urasin	CA13 CA3 CA5A CA7	4.89e-07	11	144	4	CID000084724
Drug	hydroflumethiazide	CA13 CA3 CA5A CA7	7.30e-07	12	144	4	CID000003647
Drug	mafenide acetate	CA13 CA3 CA5A CA7	1.05e-06	13	144	4	CID000003998
Drug	chlorzolamide	CA13 CA3 CA5A CA7	1.05e-06	13	144	4	CID000165323
Drug	sulfamide	BOC CA13 CA3 CA5A CA7	1.40e-06	31	144	5	CID000082267
Drug	cobalt;sulfide	CA13 CA3 CA5A CA7	1.46e-06	14	144	4	CID000159453
Drug	apraclonidine	CA13 CA3 CA5A CA7	4.38e-06	18	144	4	CID000002216
Drug	orthanilamide	CA13 CA5A CA7	4.89e-06	6	144	3	CID000072894
Drug	Methapyrilene hydrochloride [135-23-9]; Up 200; 13.4uM; MCF7; HT_HG-U133A	ADAM7 DUSP9 PTPRU NEB ATP10D DOK4 EFR3B GYG2 MAST3	5.11e-06	199	144	9	3205_UP
Drug	sulthiame	CA13 CA3 CA5A CA7	5.52e-06	19	144	4	CID000005356
Drug	AC1LCVB4	CA13 CA3 CA5A CA7	8.45e-06	21	144	4	CID000656627
Drug	AABSSN	CA13 CA3 CA5A CA7	1.03e-05	22	144	4	CID005464134
Drug	dichlorphenamide	CA13 CA3 CA5A CA7	1.24e-05	23	144	4	CID000003038
Drug	1,3-dibromopropane	BOC LIPM C3	1.36e-05	8	144	3	CID000008001
Drug	p-nitrophenyl acetate	PON1 CA13 POLR3E CA3 CA5A CA7	1.46e-05	83	144	6	CID000013243
Drug	potassium cyanate	CA13 CA3 CA5A CA7	1.48e-05	24	144	4	CID011378442
Drug	methazolamide	CA13 CA3 CA5A CA7	2.06e-05	26	144	4	CID000004100
Drug	N-methyl-1(R)-aminoindan	TRAF3IP2 KIFBP TIPARP NOMO1 GTF2IRD2B GTF2I GTF2IRD2	2.13e-05	132	144	7	CID005494442
Drug	sulfonamide	CA13 KRIT1 CA3 CA5A CA7	2.33e-05	54	144	5	CID000005333
Drug	Capobenic acid	BOC CYP27A1 YLPM1 C3	2.41e-05	27	144	4	CID000030627
Drug	imidazole	BOC PDE1B CYP4A11 FA2H CA13 C3 CA3 CA5A CA7	2.44e-05	242	144	9	CID000000795
Drug	1gaf	CA13 PTPRU CA3 CA5A CA7	2.78e-05	56	144	5	CID000444283
Drug	benzolamide	CA13 CA3 CA5A CA7	2.79e-05	28	144	4	CID000018794
Drug	rotigotine patch	BOC CA13 ABCC8 CA3 CA5A CA7	2.80e-05	93	144	6	CID003619466
Drug	AC1L9LQQ	BOC CA13 CA3 CA5A CA7	3.03e-05	57	144	5	CID000448224
Drug	Zinc chromate hydroxide	CA13 CA3 CA5A CA7	3.22e-05	29	144	4	CID000027567
Drug	thiadiazole	CA13 CA3 CA5A CA7	3.22e-05	29	144	4	CID000067518
Drug	Famotidine [76824-35-6]; Up 200; 11.8uM; MCF7; HT_HG-U133A	PON1 NEB DOK4 SSH3 EFR3B GYG2 FGFR3 MAST3	3.62e-05	196	144	8	5011_UP
Drug	Succinylsulfathiazole [116-43-8]; Up 200; 11.2uM; MCF7; HT_HG-U133A	EMC1 SZT2 ATG2A DOK4 ABCC8 C3 SEMA4A OSGIN2	3.76e-05	197	144	8	2821_UP
Drug	2-MeImpU	POLR3E GYG2	3.97e-05	2	144	2	CID000134922
Drug	dimethadione	CA13 CA3 CA5A CA7	4.81e-05	32	144	4	CID000003081
Drug	benzenesulfonamide	CA13 CA3 CA5A CA7	5.44e-05	33	144	4	CID000007370
Drug	MZ-m	CA13 CA3 CA5A CA7	5.44e-05	33	144	4	CID000001798
Drug	ebrotidine	CA13 CA3 CA5A CA7	6.14e-05	34	144	4	CID000065869
Drug	p-nitrophenyl caprylate	BOC SLC6A7 LIPM	6.76e-05	13	144	3	CID000097416
Drug	DL-arginine	ACTB ACTG1 CA13 GRIN2C TIPARP KRIT1 POLR3E CA3 CA5A CA7	6.98e-05	344	144	10	CID000000232
Drug	AC1LCVPZ	BOC ACTB PON1 ACTG1 PREP C3	7.20e-05	110	144	6	CID000656926
Drug	chlorthalidone	CA13 CA3 CA5A CA7	7.72e-05	36	144	4	CID000002732
Drug	carbamoyl phosphate	ABO CA13 C3 CA3 CA5A CA7	8.36e-05	113	144	6	CID000000278
Drug	T2755	CA13 GRIN2C CA3 CA5A CA7	8.79e-05	71	144	5	CID000005514
Drug	chlorosyl	CYP4A11 DUSP5 ABCC8 XPR1	9.58e-05	38	144	4	CID000166686
Drug	BCECF	CA13 PTPRU CA3 CA5A CA7	1.00e-04	73	144	5	CID004241719
Drug	bendrofluazide	CA13 CA3 CA5A CA7	1.06e-04	39	144	4	CID000002315
Drug	indisulam	CA13 CA3 CA5A CA7	1.06e-04	39	144	4	CID000216468
Drug	sodium bicarbonate	CA13 PIK3C2A CA3 CA5A CA7	1.07e-04	74	144	5	CID000010340
Drug	brinzolamide	CA13 CA3 CA5A CA7	1.18e-04	40	144	4	CID000068844
Drug	ethoxzolamide	CA13 CA3 CA5A CA7	1.18e-04	40	144	4	CID000003295
Drug	dinophysistoxin-4	DTX1 DTX4	1.19e-04	3	144	2	CID006441267
Drug	TSTU	BOC C3	1.19e-04	3	144	2	CID009857522
Drug	tetracontane	CYP4A11 ALKBH3	1.19e-04	3	144	2	CID000020149
Drug	Peptidoglycan monomer	BOC ABO TLR6	1.58e-04	17	144	3	CID003035036
Drug	DB08219	CA13 CA3 CA5A CA7	1.71e-04	44	144	4	CID011840966
Disease	intestinal atresia (implicated_via_orthology)	ACTB ACTG1 FGFR2	1.20e-05	10	139	3	DOID:10486 (implicated_via_orthology)
Disease	Congenital neurologic anomalies	ACTB ACTG1 SPRED1	1.20e-05	10	139	3	C0497552
Disease	Cranioschisis	ACTB ACTG1 SPRED1	1.20e-05	10	139	3	C0265541
Disease	Baraitser-Winter syndrome	ACTB ACTG1	2.20e-05	2	139	2	cv:C1853623
Disease	Isolated coronal synostosis	FGFR3 FGFR2	2.20e-05	2	139	2	cv:CN043619
Disease	Iris Coloboma with Ptosis, Hypertelorism, and Mental Retardation	ACTB ACTG1	2.20e-05	2	139	2	C1855722
Disease	Fryns-Aftimos Syndrome	ACTB ACTG1	2.20e-05	2	139	2	C1853623
Disease	Autism Spectrum Disorders	NSUN2 GTF2I TET1 USH2A IQGAP3	5.23e-05	85	139	5	C1510586
Disease	Lacrimoauriculodentodigital syndrome	FGFR3 FGFR2	6.59e-05	3	139	2	C0265269
Disease	diacylglycerol kinase beta measurement	PON1 C1R	6.59e-05	3	139	2	EFO_0801525
Disease	Levy-Hollister syndrome	FGFR3 FGFR2	6.59e-05	3	139	2	cv:C0265269
Disease	carbonic anhydrase 1 measurement	CA13 CA3	6.59e-05	3	139	2	EFO_0020227
Disease	cerebral cavernous malformation (is_implicated_in)	PON1 KRIT1	6.59e-05	3	139	2	DOID:0060669 (is_implicated_in)
Disease	Saethre-Chotzen Syndrome	FGFR3 FGFR2	6.59e-05	3	139	2	C0175699
Disease	Congenital hypoplasia of radius	FGFR3 FGFR2	6.59e-05	3	139	2	C0685381
Disease	TWIST1-related craniosynostosis	FGFR3 FGFR2	1.31e-04	4	139	2	cv:C4551902
Disease	bone disease (implicated_via_orthology)	FGFR3 FGFR2	2.18e-04	5	139	2	DOID:0080001 (implicated_via_orthology)
Disease	CCL25 measurement	ABO PIK3C2A	2.18e-04	5	139	2	EFO_0010768
Disease	Paratuberculosis	C1R C3	3.26e-04	6	139	2	C0030524
Disease	X-14939 measurement	CYP4A11 CYP4A22	3.26e-04	6	139	2	EFO_0800747
Disease	Craniosynostosis syndrome	FGFR3 FGFR2	4.56e-04	7	139	2	cv:C0010278
Disease	Uveoretinal Coloboma	ACTB ACTG1	4.56e-04	7	139	2	C4554007
Disease	nemaline myopathy (implicated_via_orthology)	ACTB NEB	6.06e-04	8	139	2	DOID:3191 (implicated_via_orthology)
Disease	Moyamoya disease (implicated_via_orthology)	ACTB ACTG1	6.06e-04	8	139	2	DOID:13099 (implicated_via_orthology)
Disease	autosomal dominant nonsyndromic deafness 20 (implicated_via_orthology)	ACTB ACTG1	6.06e-04	8	139	2	DOID:0110550 (implicated_via_orthology)
Disease	Baraitser-Winter syndrome 1 (implicated_via_orthology)	ACTB ACTG1	6.06e-04	8	139	2	DOID:0081112 (implicated_via_orthology)
Disease	thoracic aortic aneurysm (implicated_via_orthology)	ACTB ACTG1	6.06e-04	8	139	2	DOID:14004 (implicated_via_orthology)
Disease	Congenital ocular coloboma (disorder)	ACTB ACTG1	7.76e-04	9	139	2	C0009363
Disease	protein intake measurement	ABO KLB	9.67e-04	10	139	2	EFO_0010810
Disease	patent ductus arteriosus (implicated_via_orthology)	ACTB ACTG1	9.67e-04	10	139	2	DOID:13832 (implicated_via_orthology)
Disease	autosomal recessive polycystic kidney disease (biomarker_via_orthology)	CYP4A11 CYP4A22	1.18e-03	11	139	2	DOID:0110861 (biomarker_via_orthology)
Disease	Intellectual Disability	CHL1 KIFBP FHIP2A NSUN2 WDR26 FGFR2 RAB39B EIF2A	1.31e-03	447	139	8	C3714756
Disease	craniosynostosis (is_implicated_in)	FGFR3 FGFR2	1.41e-03	12	139	2	DOID:2340 (is_implicated_in)
Disease	Spina Bifida	PON1 FGFR2	1.41e-03	12	139	2	C0080178
Disease	dodecanedioate measurement	CYP4A11 XPR1	1.41e-03	12	139	2	EFO_0021054
Disease	Status Dysraphicus	PON1 FGFR2	1.41e-03	12	139	2	C0038219
Disease	Rachischisis	PON1 FGFR2	1.41e-03	12	139	2	C0266508
Disease	cognitive inhibition measurement	TRPM6 PXDNL USH2A	1.71e-03	50	139	3	EFO_0007969
Disease	Epilepsy	ACTG1 FGFR3 RAB39B EIF2A	1.79e-03	109	139	4	C0014544
Disease	sickle cell anemia (is_marker_for)	PON1 C3	1.93e-03	14	139	2	DOID:10923 (is_marker_for)
Disease	glucose measurement	ABO DUSP9 GRB14 EPB41L4A ARMC2 AXIN1 KDM2B	2.22e-03	380	139	7	EFO_0004468
Disease	hip bone mineral density, hip bone size	NUP88 TMEM260 FGFR2	2.36e-03	56	139	3	EFO_0004844, EFO_0007702
Disease	isocitrate measurement	PREP TRPM8	2.53e-03	16	139	2	EFO_0010505
Disease	Amyotrophic Lateral Sclerosis	PON1 FIG4 SCFD1	2.61e-03	58	139	3	C0002736
Disease	creatine kinase measurement	ABO NEB IQGAP3	2.74e-03	59	139	3	EFO_0004534
Disease	Kuhnt-Junius degeneration (is_implicated_in)	PON1 C3	2.86e-03	17	139	2	DOID:10873 (is_implicated_in)
Disease	Brachycephaly	FGFR3 FGFR2	2.86e-03	17	139	2	C0221356
Disease	non-Hodgkin lymphoma (is_implicated_in)	PON1 TMEM260	2.86e-03	17	139	2	DOID:0060060 (is_implicated_in)
Disease	Malignant neoplasm of endometrium	AXIN1 FGFR2	3.21e-03	18	139	2	C0007103
Disease	level of Sphingomyelin (d34:1) in blood serum	USP24 NPFFR2	3.21e-03	18	139	2	OBA_2045175
Disease	Carcinoma in situ of endometrium	AXIN1 FGFR2	3.21e-03	18	139	2	C0346191
Disease	Disorder of eye	CYP27A1 PPT1 RIMS1 SEMA4A USH2A	3.37e-03	212	139	5	C0015397
Disease	level of Sterol ester (27:1/20:3) in blood serum	USP24 NOMO1	3.57e-03	19	139	2	OBA_2045199
Disease	hip bone size	NUP88 TMEM260 FGFR2	3.61e-03	65	139	3	EFO_0004844
Disease	glycine measurement	ABO GRB14 GVINP1 MAST3	4.08e-03	137	139	4	EFO_0009767
Disease	Profound Mental Retardation	CHL1 KIFBP FGFR2 RAB39B	4.30e-03	139	139	4	C0020796
Disease	Mental Retardation, Psychosocial	CHL1 KIFBP FGFR2 RAB39B	4.30e-03	139	139	4	C0025363
Disease	Mental deficiency	CHL1 KIFBP FGFR2 RAB39B	4.30e-03	139	139	4	C0917816
Disease	COVID-19 (is_implicated_in)	ABO C3	4.36e-03	21	139	2	DOID:0080600 (is_implicated_in)

Protein segments in the cluster

Peptide	Gene	Start	Entry
AELHLVHWNPKYNTF	CA3	116	P07451
KLPHAWIHTDASLVY	C16orf89	131	Q6UX73
YLTLSSIKDHPWHIQ	ARL5B	141	Q96KC2
IEAVWHDESHLNKYL	ABO	296	P16442
DHVVLLSGKWLYSHV	ADAM7	286	Q9H2U9
TLKYPIEHGIVTNWD	ACTB	66	P60709
TLKYPIEHGIVTNWD	ACTG1	66	P63261
DPDLKNYHKLHWETE	ARMC2	826	Q8NEN0
EHSEIHTKLYFLQWL	GVINP1	1336	Q7Z2Y8
QLWHPHEQDYKKSSL	GPR19	296	Q15760
TQADWQHRVPKEYHS	ALKBH3	251	Q96Q83
PNLSYIIGKDTWVEH	C3	1616	P01024
SWILYALATHPKHQE	CYP4A11	331	Q02928
AAELHVVHWNSDKYP	CA13	116	Q8N1Q1
SPEIWELLLKSVHLY	DPY19L3	501	Q6ZPD9
SAHSKHPEQWDLDYS	ANO2	721	Q9NQ90
ITIQHAYEKQHPWID	DTX4	111	Q9Y2E6
WILTAAHTLYPKEHE	C1R	496	P00736
SVDALTIHNHLWQPK	CAMSAP1	1576	Q5T5Y3
QYEHASIHLWDLLEG	CAPRIN1	206	Q14444
SEVPIWLDYHGKHVT	ATG2A	1671	Q2TAZ0
QKSEAYLPHTFWITL	ATP10D	1186	Q9P241
EHIIHMPQEDYISWL	CCDC60	521	Q8IWA6
ESIPHWIHEIEKYGA	RAB19	106	A4D1S5
HEWLEETKVHVQPYQ	RAB39B	101	Q96DA2
HPIWNVNDTKHHLYS	NPFFR2	116	Q9Y5X5
YEILATHPTWALKEA	NOMO3	181	P69849
HEHYLVHKPEKVTWT	CRYZL1	106	O95825
DCLKHHTVLPYHWQI	TIPARP	256	Q7Z3E1
YPEELAWHTNLSRKI	NSUN2	121	Q08J23
YSDAQPHIQWIKHVE	FGFR2	281	P21802
YEILATHPTWALKEA	NOMO2	181	Q5JPE7
LTEQYLHKDRWPEVS	MAP1A	1176	P78559
PLHIYWMNIELEHIE	CHL1	161	O00533
IYHKNIPEWAHVDFI	LIPM	376	Q5VYY2
YKDPATLRQHEKTHW	HIC1	516	Q14526
IAHNLYWLLKDALHD	PIK3C2A	1006	O00443
LHAADISHPTKQWLV	PDE1B	366	Q01064
LIHLDNHSLWEPKVF	EFR3B	256	Q9Y2G0
YEILATHPTWALKEA	NOMO1	181	Q15155
HYKQIPISDHWSQNL	DUSP9	251	Q99956
KSKAPHWTNRILHEY	KRIT1	591	O00522
SKIEQHLIFWLPAHD	GDPD4	356	Q6W3E5
NAYEKQHPWLDLSSL	DTX1	131	Q86Y01
VHTDPVHLYKNWINQ	IQGAP3	1071	Q86VI3
ETHIVDSPNYKLWHL	PTPRT	336	O14522
AVSLQTYKLWHLDPD	PTPRU	336	Q92729
ALLDDEPHWYKLQTH	RIMS1	856	Q86UR5
EPHWYKLQTHDESSL	RIMS1	861	Q86UR5
EWKFLPSLVNLHSAH	KICS2	206	Q96MD2
VHWFLDKTPLHANEL	OBSCN	3036	Q5VST9
LDDEPHWYKLQTHDV	RIMS2	921	Q9UQ26
HWYKLQTHDVSSLPL	RIMS2	926	Q9UQ26
WHDPIKEDVYRNHSI	PPT1	186	P50897
QHFEWLVKYSPLHNV	PREP	606	P48147
HLGEKYDEWVHQPVT	FA2H	136	Q7L5A8
NWSTTDIHKHLPFIY	GYG2	206	O15488
YDYPSVLHWKLEQHH	OSGIN2	101	Q9Y236
GAELQHITYSHWLPK	PXDNL	1006	A1KZ92
PAELHLVHWNSVKYQ	CA5A	151	P35218
WEYDPVKLTLQHVNS	GALNT1	506	Q10472
KWTDLALQYLHENVP	ANAPC13	56	Q9BS18
PTLHNLALYEEWVLS	KDM2B	266	Q8NHM5
DKYWHSISHLQPETS	BOC	771	Q9BWV1
LDTLTEHYDIPKVSW	FAM32A	96	Q9Y421
HLWELPTDFYLHHKN	FIG4	606	Q92562
PYLKWAESLHSLLDD	AXIN1	81	O15169
SWILYALATHPKHQE	CYP4A22	331	Q5TCH4
WALYHLSKDPEIQEA	CYP27A1	346	Q02318
HHWLYRLQEAPKKES	IFNL2	156	Q8IZJ0
THEVKQHPFFLALDW	MAST3	631	O60307
LEHWIFNSEAHLLPI	MAN1A1	626	P33908
VTLYHWDLPLALQEK	KLB	191	Q86Z14
LLILKNHYIDDHSWT	GRB14	136	Q14449
PLEYLEKLHYKHESW	DCK	201	P27707
FPSELHLVHWNAKKY	CA7	116	P43166
KLDHLHWPVFSDLDN	EEF2K	406	O00418
LKWVEHLPESDSIHY	EMC1	161	Q8N766
ILHKYDVPSNAELWQ	EIF2A	396	Q9BY44
KVYSDAQPHIQWLKH	FGFR3	276	P22607
PLQEDFVYHWKAITH	FHIP2A	21	Q5W0V3
HPENYDLATLKWILE	GTF2IRD2	156	Q86UP8
HPENYDLATLKWILE	GTF2IRD2B	156	Q6EKJ0
HPENYDLATLKWILE	GTF2I	161	P78347
SYQELVKVWHPDHNL	DNAJC22	296	Q8N4W6
HQTYWLDPAKTLAEH	EPB41L4A	66	Q9HCS5
KDIRWLSPHSALHVE	RUBCN	86	Q92622
LQKKHAEEPWVHLHY	POLR3E	196	Q9NVU0
THLHYKWIPVEDSHT	DUSP5	221	Q16690
KLQITHENIYLWDIH	DOK4	156	Q8TEW6
HENIYLWDIHNPRVK	DOK4	161	Q8TEW6
KRQLEHNAYHPIEWA	KIFBP	236	Q96EK5
LESYPLNAHCEWTIH	PAMR1	141	Q6UXH9
LTLKHAAWYPSEILD	NUP88	171	Q99567
GTVDLQHVLEHWYLL	SYT8	221	Q8NBV8
KYVLHSVDLQSENPW	SYVN1	191	Q86TM6
PGIWKHLQDLTYSEI	SZT2	921	Q5T011
SHVIGHLKPNTEYWI	USH2A	2981	O75445
WTIEAPEGQKLHLHF	SEZ6L	481	Q9BYH1
IDHDITSQLYAWPLL	TBC1D31	561	Q96DN5
HVYEKHANWTLTPLK	PON1	246	P27169
KPFEEHWRKHTLSYV	SDHA	616	P31040
PVLKTDNFLRWLHHD	SEMA4A	216	Q9H3S1
EEPHYIEIWKKHLEA	SECISBP2	816	Q96T21
LHIPWSYEDSLTIAQ	PGAP1	526	Q75T13
WDPLSTDYLLVVNLH	WDR17	231	Q8IZU2
LELLKHNEAYTWTNP	OSBPL2	221	Q9H1P3
TPQFHHLLSSKVWIE	SLC6A7	276	Q99884
AQLLPHWKETHRFIE	SSH3	386	Q8TE77
YLDEKQHAWLPLTIE	TCL1A	26	P56279
KLPHIDEYWSDSEHI	TET1	1986	Q8NFU7
VTHKLQYLPHADWII	ABCC8	886	Q09428
KEHVPTWLQNTHVYS	TRAF3IP2	526	O43734
YQIIETAHWKHPIFS	CNBD2	46	Q96M20
HLTISHGPWIDEEYK	NLRP9	971	Q7RTR0
HLSAHITPEWRKQYI	XPR1	6	Q9UBH6
LHHWVPVAETKFLVA	XYLT1	826	Q86Y38
KHILIYEQHWKPDAL	TRPM6	426	Q9BX84
LYHLLSPWAHSANKD	TBC1D8B	846	Q0IIM8
WALTPTHYLTKHDVE	RPN2	21	P04844
KWDEINILATYHPAD	PPP1R2B	46	Q6NXS1
KHLWLEFSHPVESLA	SPIRE2	521	Q8WWL2
IYNKVTPTFHHWKID	SPRED1	81	Q7Z699
DLATPLHHTWTYQAL	SCFD1	266	Q8WVM8
FAAEDSVQWLLKHHP	PPP1R36	46	Q96LQ0
CHLKWLADYLHTNPI	SLIT2	436	O94813
EFVVWNPRSHEKLHI	WDR6	636	Q9NNW5
HDSAWVKSELVPYLE	TLR6	651	Q9Y2C9
LWEEQLHSYPHKDQL	YLPM1	461	P49750
YRIFHSWLQPEKHSK	ZSCAN4	66	Q8NAM6
LESRVLTDHWSIPYK	USP24	131	Q9UPU5
LTDHWSIPYKREESL	USP24	136	Q9UPU5
SHLLTEPVKDHNWRY	TRIM16	116	O95361
SDYIIHQTVHTWKKP	ZNF23	601	P17027
EDHKVYIWHKRSELP	WDR26	591	Q9H7D7
HSYPGKQDHLWIIIE	TEX15	1846	Q9BXT5
AEILYELLTQHWHLK	TRPM8	126	Q7Z2W7
EKSYQVISWLAPEDH	UGT3A2	71	Q3SY77
LSTYLETHNWPEALK	TRMT10B	286	Q6PF06
NLEWLHLAKHEAIVY	WDR87	2561	Q6ZQQ6
KEHLSSPVYIWDLAR	TMEM14EP	61	Q6UXP3
LTVWKELEQKPTHHY	WDR81	1851	Q562E7
TPHSWEEELNHYALK	ZMYM4	1101	Q5VZL5
KEIVYLQKEHPVNWH	TMEM260	626	Q9NX78
KSFYWKAHLIQHERP	ZNF658B	151	Q4V348
VLKLWHNSITYIPEH	LRRC8C	641	Q8TDW0
NSIWPLKALDHHVIS	LRRIQ3	146	A6PVS8
TLVSDVDYKHPLHEW	NEB	3346	P20929
VSDIDYKHPLHEWTC	NEB	3591	P20929
CYVWDTPEILHAKHA	NEB	4856	P20929
EHLVYWKLRHSVPNS	GRIN2C	836	Q14957